HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group

This article was originally published in The Tan Sheet

Executive Summary

FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.

You may also be interested in...



CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology

FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.

FDA Nanotech Guidance Takes Small Step Forward

FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.

‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney

Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.

Topics

UsernamePublicRestriction

Register

RS134178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel